Dr. Robert (Robin) Hines is a cancer epidemiologist and cancer health services researcher. He received his Ph.D. in Epidemiology from the University of Alabama at Birmingham Ryals School of Public Health in 2009. The themes of Dr. Hines’ research concern improving the quality of cancer care and investigating trends and causes of disparities in cancer outcomes. Dr. Hines has conducted large scale epidemiologic studies to quantify and explain causes of disparate cancer outcomes for various segments of the population defined by race-ethnicity, socioeconomic status, geography, and age. He has also conducted observational comparative effectiveness research designed to provide evidence of treatment effectiveness when the data from randomized controlled trials was either nonexistent or equivocal. Overall, the goal of Dr. Hines’ research is to improve patient-centered, clinical, and population-level cancer outcomes. Dr. Hines’ research has been funded by the National Institutes of Health, the Florida Breast Cancer Foundation, UCF, and others.
The UCF College of Medicine welcomed Dr. Hines as an Associate Professor of Medicine in June of 2016. Dr. Hines is a member of the Department of Population Health Sciences. In the College of Medicine, Dr. Hines teaches epidemiology, mentors medical students on their research projects, and serves as a facilitator for the Making of a Physician course. Dr. Hines is Chair of Institutional Review Board 2 at UCF and also Chair of the Cancer Subgroup of the Population Health Collaborative Council.
Dr. Hines has served as a grant reviewer for the National Cancer Institute. He is an Associate Editor for BMC Cancer and a reviewer for numerous scientific journals.
Recent Grants and Contracts
1R03CA241788-01A1 Hines (PI) 2020-22
National Cancer Institute
Prevention and Treatment of Oxaliplatin-Induced Peripheral Neuropathy
Florida Breast Cancer Foundation Hines (PI) 2020-21
Causes of Racial/Ethnic Disparities in Breast Cancer Outcomes in Florida
Centers for Disease Control Hines (co-PI, Evaluation) 2020-2025
Florida Department of Health
Florida Colorectal Cancer Control Program
Selected Recent Publications
- Hines RB, Jiban MJH, Lee E, Odahowski C, Wallace AS, Adams SJE, Rahman S, Zhang S. Characteristics Associated with Nonreceipt of Surveillance Testing and the Relationship with Survival in Stage II and III Colon Cancer. Am J Epidemiol. In press.
- Lee E, Eum SY, Slifer SH, Martin ER, Takita C, Wright JL, Hines RB, Hu JJ. Association Between Polymorphisms in DNA Damage Repair Genes and Radiation Therapy-Induced Early Adverse Skin Reactions in a Breast Cancer Population: A Polygenic Risk Score Approach. Int J Radiat Oncol Biol Phys. 2020;106: 948-957.
- Johnson AM, Johnson A, Hines RB, Mohammadi R. Neighborhood context and non-small cell lung cancer outcomes in Florida non-elderly patients by race/ethnicity. Lung Cancer. 2020;142: 20-27.
- Hines RB, Jiban MJH, Specogna AV, Vishnubhotla P, Lee E, Zhang S. Surveillance Colonoscopy in Older Stage I Colon Cancer Patients and the Association with Colon Cancer-Specific Mortality. Am J Gastroenterol. 2020.
- Lee E, Hines R, Schulz V, Rovito M, Garcia J. Diet Quality in a Nationally Representative Sample of American Adult Cancer Survivors (P05-028-19). Curr Dev Nutr. 2019 Jun 13;3(Suppl 1).
- Hines RB, Jiban MJH, Specogna AV, Vishnubhotla P, Lee E, Zhang S. The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study. BMC Cancer. 2019;19: 418.
- Hines RB, Jiban JH, Choudhury K, Loerzel V, Specogna A, Troy S, Zhang S. Post-Treatment Surveillance Testing of Colorectal Cancer Patients and the Association with Survival: Protocol for a Retrospective Cohort Study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Database. BMJ Open. 2018; 8(4):e022393.
- Redmond ML, Dong F, Twumasi-Ankrah P, Hines RB, Jacobson, LT, Ablah E, Johnston, J, Collins TC. Food insecurity and pre-hypertension, pre-diabetes in adult women: Results from the 2007-2010 National Health and Nutrition Examination Survey. J Health Dispar Res Pract. 2018; 11(1): 56-73.
- Hines RB, Bimali M, Johnson AM, Bayakly AR, Collins TC. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort. Cancer Epidemiol. 2016;44:77-83.